To fill this knowledge gap, this study aimed to evaluate treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis who started therapies with DMARD and anti-TNF drugs. The gene discussed is TNF; the disease is ankylosing spondylitis.